Notice of Intent To Award Affordable Care Act Funding, DP-09-001, 52663-52664 [2011-21343]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 163 / Tuesday, August 23, 2011 / Notices
information on the operation of their
EAS equipment during a national test of
the EAS: (1) Whether they received the
alert message during the designated test;
(2) whether they retransmitted the alert;
and (3) if they were not able to receive
and/or transmit the alert, their ‘best
effort’ diagnostic analysis regarding the
cause or causes for such failure. OMB
also authorized the Commission to
require EAS Participants to provide it
with the date/time of receipt of the EAN
message by all stations; and the date/
time of receipt of the EAT message by
all stations; a description of their station
identification and level of designation
(PEP, LP–1, etc.); who they were
monitoring at the time of the test, and
the make and model number of the EAS
equipment that they utilized.
In the Third Report and Order in EB
Docket No. 04–296, FCC 09–10, the
Commission adopted the foregoing rule
requirements. In addition, the
Commission decided that test data will
be presumed confidential and
disclosure of test data will be limited to
FEMA, NWS and EOP at the federal
level. At the State level, test data will be
made available only to State government
emergency management agencies that
have confidential treatment protections
at least equal to FOIA. The process by
which these agencies would receive test
data will comport with those used to
provide access to the Commission’s
NORS and DIRS data. We seek comment
on this revision of the approved
collection.
In the Third Report and Order, the
Commission also indicated that it would
establish a voluntary electronic
reporting system that EAS test
participants may use as part of their
participation in the national EAS test.
The Commission noted that using this
system, EAS test participants could
input the same information that they
were already required to file manually
via a web-based interface into a
confidential database that the
Commission would use to monitor and
assess the test. This information would
include identifying information such as
station call letters, license identification
number, geographic coordinates, EAS
assignment (LP, NP, etc), EAS
monitoring assignment, as well as a 24/
7 emergency contact for the EAS
Participant. The only difference, other
than the electronic nature of the filing,
would the the timing of the collection.
On the day of the test, EAS Test
participants would be able to input
immediate test results, (e.g., was the
EAN received and did it pass) into a
web-based interface. Test participants
would submit the identifying data prior
to the test date, and the remaining data
VerDate Mar<15>2010
16:33 Aug 22, 2011
Jkt 223001
52663
Determination of Insufficient Assets To
Satisfy Claims Against Financial
Institution in Receivership
Section 11(d)(11)(A) of the FDI Act,
12 U.S.C. 1821(d)(11)(A), sets forth the
order of priority for distribution of
amounts realized from the liquidation or
other resolution of an insured
depository institution to pay claims.
Under the statutory order of priority,
administrative expenses and deposit
liabilities must be paid in full before
any distribution may be made to general
unsecured creditors or any lower
priority claims.
As of June 30, 2011, the value of
assets available for distribution by the
Receiver, together with maximum
possible recoveries on claims against
directors, officers, and other
professionals was $86,789,915. As of the
same date, administrative expenses and
depositor liabilities equaled
$220,441,349, exceeding available assets
and potential recoveries by
$133,651,434. Accordingly, the FDIC
has determined that insufficient assets
exist to make any distribution on
general unsecured creditor claims (and
any lower priority claims) and therefore
all such claims, asserted or unasserted,
will recover nothing and have no value.
Federal Deposit Insurance
Corporation (FDIC).
ACTION: Notice.
Dated: August 18, 2011.
Robert E. Feldman,
Executive Secretary.
The FDIC has determined that
insufficient assets exist in the
receivership of Sun American Bank,
Boca Raton, Florida, to make any
distribution on general unsecured
claims, and therefore such claims will
recover nothing and have no value.
DATES: The FDIC made its determination
on August 18, 2011.
FOR FURTHER INFORMATION CONTACT: If
you have questions regarding this
notice, you may contact an FDIC Claims
Agent at (904) 256–3925. Written
correspondence may also be mailed to
FDIC as Receiver of Sun American
Bank, Attention: Claims Agent, 7777
Baymeadows Way West, Jacksonville,
Florida 32256.
SUPPLEMENTARY INFORMATION: On March
5, 2010, Sun American Bank, Boca
Raton, Florida, (FIN #10192) was closed
by the Florida Office of Financial
Regulation, and the Federal Deposit
Insurance Corporation (‘‘FDIC’’) was
appointed as its receiver (‘‘Receiver’’).
In complying with its statutory duty to
resolve the institution in the method
that is least costly to the deposit
insurance fund, see 12 U.S.C. 1823(c)(4),
the FDIC facilitated a transaction with
First-Citizens Bank & Trust Company,
Raleigh, North Carolina, to acquire all of
the deposits and most of the assets of
the failed institution.
BILLING CODE 6714–01–P
called for by our reporting rules (e.g. the
detailed test results) within the 45 day
period. The Commission believes that
structuring an electronic reporting
system in this fashion would allow the
participants to populate the database
with known information well prior to
the test, and thus be able to provide the
Commission with actual test data, both
close to real-time and within a
reasonable period in a minimally
burdensome fashion. The Commission
also seeks comment on this revision of
the approved collection.
Federal Communications Commission.
Marlene H. Dortch,
Secretary, Office of the Secretary, Office of
Managing Director.
[FR Doc. 2011–21545 Filed 8–22–11; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
AGENCY:
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
[FR Doc. 2011–21546 Filed 8–22–11; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Notice of Intent To Award Affordable
Care Act Funding, DP–09–001
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice provides public
announcement of CDC’s intent to fund
Approved cooperative agreement
applications previously received and
competed in response to CDC Funding
Opportunity, RFA–DP–09–001, ‘‘Health
Promotion and Disease Prevention
Research Centers (U48).’’ It is the intent
of CDC to fund the applications with
Patient Protection Affordable Care Act
(ACA), Section 4002, appropriations.
CFDA Number 93.542 is the ACAspecific CFDA number for this
initiative.
SUMMARY:
Award Information
Approximate Current Fiscal Year
Funding: $10,000,000.
E:\FR\FM\23AUN1.SGM
23AUN1
52664
Federal Register / Vol. 76, No. 163 / Tuesday, August 23, 2011 / Notices
Approximate Number of Awards: 15–
17.
Approximate Average Award:
$625,000.
Fiscal Year Funds: 2011.
Anticipated Award Date: September
30, 2011.
Budget Period: 12 months.
Project Period: 1 year.
Application Selection Process
Only applicants who have applied for
and have been selected as Prevention
Research Centers under CDC Program
Announcement DP–09–001 were
eligible to apply for the annual
continuation funding.
mstockstill on DSK4VPTVN1PROD with NOTICES
Funding Authority
CDC will add the following Authority
to that which is reflected in the
published Funding Opportunity:
—Section 4002 of the Patient Protection
and Affordable Care Act (Pub. L. 111–
148.).
DATES: The effective date for this action
is August 23, 2011 and remains in effect
until the expiration of the project period
of the ACA funded applications.
FOR FURTHER INFORMATION CONTACT:
Elmira Benson, Deputy Director,
Procurement and Grants Office, Centers
for Disease Control and Prevention,
2920 Brandywine Road, Atlanta, GA
30341, telephone (770) 488–2802, e-mail
Elmira.Benson@cdc.gov.
SUPPLEMENTARY INFORMATION: On March
23, 2010, the President signed into law
the Patient Protection and Affordable
Care Act (ACA). ACA is designed to
improve and expand the scope of health
care coverage for Americans. Cost
savings through disease prevention is an
important element of this legislation
and ACA has established a Prevention
and Public Health Fund (PPHF) for this
purpose. Specifically, the legislation
states in Section 4002 that the PPHF is
to ‘‘provide for expanded and sustained
national investment in prevention and
public health programs to improve
health and help restrain the rate of
growth in private and public sector
health care costs. ACA and the
Prevention and Public Health Fund
make improving public health a priority
with investments to improve public
health.
The PPHF states that the Secretary
shall transfer amounts in the Fund to
accounts within the Department of
Health and Human Services to increase
funding, over the fiscal year 2008 level,
for programs authorized by the Public
Health Services Act, for prevention,
wellness and public health activities
including prevention research and
health screenings, such as the
VerDate Mar<15>2010
16:33 Aug 22, 2011
Jkt 223001
Community Transformation Grant
Program, the Education and Outreach
Campaign for Preventative Benefits, and
Immunization Programs.
ACA legislation affords an important
opportunity to advance public health
across the lifespan and to reduce health
disparities by supporting an intensive
community approach to chronic disease
prevention and control.
Therefore, the FOA program activities
CDC proposes to fund with ACA
appropriations are authorized by the
amendment to the Public Health
Services Act which authorized the
Prevention and Wellness Program.
Dated: August 9, 2011.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2011–21343 Filed 8–22–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–240]
Request for Information:
Announcement of Carcinogen and
Recommended Exposure Limit (REL)
Policy Assessment
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of public comment
period.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC) intends to
review its approach to classifying
carcinogens and establishing
recommended exposure limits (RELs)
for occupational exposures to hazards
associated with cancer. As part of this
effort, NIOSH is requesting initial input
on these issues (including answers to
the 5 questions in the following
section), to be submitted to the NIOSH
Docket number 240, for a comment
period lasting through September 22,
2011. This information will be taken
under consideration and used to inform
NIOSH efforts to assess and document
its carcinogen policy and REL policy
regarding occupational hazards
associated with cancer. NIOSH has also
created a new NIOSH Cancer and REL
Policy Web Topic Page [see https://
www.cdc.gov/niosh/topics/cancer/
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
policy.html] to provide additional
details about this effort and progress
updates.
Public Comment Period: Comments
must be received by September 22,
2011.
ADDRESSES: Written comments,
identified by docket number NIOSH–
240, may be submitted by any of the
following methods:
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
• Facsimile: (513) 533–8285.
• E-mail: nioshdocket@cdc.gov.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Room 111, Cincinnati, Ohio 45226. A
complete electronic docket containing
all comments submitted will be
available on the NIOSH Web page at
https://www.cdc.gov/niosh/docket, and
comments will be available in writing
by request. NIOSH includes all
comments received without change in
the docket, including any personal
information provided. All electronic
comments should be formatted as
Microsoft Word. Please make reference
to docket number NIOSH–240.
Background
NIOSH is announcing a Request for
Information on key issues identified and
associated with the NIOSH Carcinogen
and REL policies. Special emphasis will
be placed on consideration of technical
and scientific issues with the current
NIOSH Cancer and REL Policies that
require further examination including
the following:
(1) Should there explicitly be a
carcinogen policy as opposed to a
broader policy on toxicant identification
and classification (e.g. carcinogens,
reproductive hazards, neurotoxic
agents)?
(2) What evidence should form the
basis for determining that substances are
carcinogens? How should these criteria
correspond to nomenclature and
categorizations (e.g., known, reasonably
anticipated, etc.)?
(3) Should 1 in 1,000 working lifetime
risk (for persons occupationally
exposed) be the target level for a
recommended exposure limit (REL) for
carcinogens or should lower targets be
considered?
(4) In establishing NIOSH RELs, how
should the phrase ‘‘to the extent
feasible’’ (defined in the 1995 NIOSH
Recommended Exposure Limit Policy)
be interpreted and applied?
(5) In the absence of data, what
uncertainties or assumptions are
E:\FR\FM\23AUN1.SGM
23AUN1
]]>Agencies
[Federal Register Volume 76, Number 163 (Tuesday, August 23, 2011)]
[Notices]
[Pages 52663-52664]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21343]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Notice of Intent To Award Affordable Care Act Funding, DP-09-001
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice provides public announcement of CDC's intent to
fund Approved cooperative agreement applications previously received
and competed in response to CDC Funding Opportunity, RFA-DP-09-001,
``Health Promotion and Disease Prevention Research Centers (U48).'' It
is the intent of CDC to fund the applications with Patient Protection
Affordable Care Act (ACA), Section 4002, appropriations.
CFDA Number 93.542 is the ACA-specific CFDA number for this
initiative.
Award Information
Approximate Current Fiscal Year Funding: $10,000,000.
[[Page 52664]]
Approximate Number of Awards: 15-17.
Approximate Average Award: $625,000.
Fiscal Year Funds: 2011.
Anticipated Award Date: September 30, 2011.
Budget Period: 12 months.
Project Period: 1 year.
Application Selection Process
Only applicants who have applied for and have been selected as
Prevention Research Centers under CDC Program Announcement DP-09-001
were eligible to apply for the annual continuation funding.
Funding Authority
CDC will add the following Authority to that which is reflected in
the published Funding Opportunity:
--Section 4002 of the Patient Protection and Affordable Care Act (Pub.
L. 111-148.).
DATES: The effective date for this action is August 23, 2011 and
remains in effect until the expiration of the project period of the ACA
funded applications.
FOR FURTHER INFORMATION CONTACT: Elmira Benson, Deputy Director,
Procurement and Grants Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road, Atlanta, GA 30341, telephone (770)
488-2802, e-mail Elmira.Benson@cdc.gov.
SUPPLEMENTARY INFORMATION: On March 23, 2010, the President signed into
law the Patient Protection and Affordable Care Act (ACA). ACA is
designed to improve and expand the scope of health care coverage for
Americans. Cost savings through disease prevention is an important
element of this legislation and ACA has established a Prevention and
Public Health Fund (PPHF) for this purpose. Specifically, the
legislation states in Section 4002 that the PPHF is to ``provide for
expanded and sustained national investment in prevention and public
health programs to improve health and help restrain the rate of growth
in private and public sector health care costs. ACA and the Prevention
and Public Health Fund make improving public health a priority with
investments to improve public health.
The PPHF states that the Secretary shall transfer amounts in the
Fund to accounts within the Department of Health and Human Services to
increase funding, over the fiscal year 2008 level, for programs
authorized by the Public Health Services Act, for prevention, wellness
and public health activities including prevention research and health
screenings, such as the Community Transformation Grant Program, the
Education and Outreach Campaign for Preventative Benefits, and
Immunization Programs.
ACA legislation affords an important opportunity to advance public
health across the lifespan and to reduce health disparities by
supporting an intensive community approach to chronic disease
prevention and control.
Therefore, the FOA program activities CDC proposes to fund with ACA
appropriations are authorized by the amendment to the Public Health
Services Act which authorized the Prevention and Wellness Program.
Dated: August 9, 2011.
Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and
Prevention.
[FR Doc. 2011-21343 Filed 8-22-11; 8:45 am]
BILLING CODE 4163-18-P
